Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The scales and tales of myelination: using zebrafish and mouse to study myelinating glia.
Genzyme’s LEMTRADA™ (alemtuzumab) application for MS accepted for review by the FDA
Multiple Sclerosis and Pregnancy: Current Considerations.
Interferon β for secondary progressive multiple sclerosis: a systematic review.
The interaction of Q analogs, particularly hydroxydecyl benzoquinone (idebenone), with the respiratory complexes of heart mitochondria.
Rituximab product approval information - Licensing action
Zebrafish myelination: a transparent model for remyelination?
Alemtuzumab and multiple sclerosis: therapeutic application.
Recent advances in the drug discovery of metabotropic glutamate receptor 4 (mGluR4) activators for the treatment of CNS and non-CNS disorders.
Down Syndrome Developmental Brain Transcriptome Reveals Defective Oligodendrocyte Differentiation and Myelination.
Biogen Idec completes purchase of full rights and control of Tysabri®
Phase III study with teriflunomide versus placebo in patients with first clinical symptom of multiple sclerosis (TOPIC)
Inflammation-induced fatigue: Exploring neurobiological mechanisms and potential treatments
Fingolimod attenuates ceramide-induced blood-brain barrier dysfunction in multiple sclerosis by targeting reactive astrocytes.
Treatment of progressive multiple sclerosis: what works, what does not, and what is needed.
Effect of immunosuppressive cladribine treatment on serum leucocytes system in two-year clinical trial in patients with chronic progressive multiple sclerosis.
Glatiramer acetate ameliorates inflammatory bowel disease in mice through the induction of Qa-1-restricted CD8⁺ regulatory cells.
Translating state-of-the-art spinal cord MRI techniques to clinical use: A systematic review of clinical studies utilizing DTI, MT, MWF, MRS, and fMRI.
Interferon beta for secondary progressive multiple sclerosis.
Placebo-controlled trial of oral laquinimod for multiple sclerosis.
Receptos doses first patient in Phase 2 trial for RPC1063 in ulcerative colitis
Immunological mechanisms underlying delayed-type hypersensitivity reactions to glatiramer acetate.
Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis.
The selective sphingosine 1-phosphate receptor modulator BAF312 redirects lymphocyte distribution and has species-specific effects on heart rate.
Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis.

Pages